Authors: Henretig, F

Citation: F. Henretig, Biological and chemical terrorism defense: A view from the "front lines" of public health, AM J PUB HE, 91(5), 2001, pp. 718-720

Authors: Bornschein, RL Chisolm, JJ Damokosh, AI Dockery, DW Fay, ME Jones, RL Rhoads, GG Ragan, NB Rogan, WJ Salganik, M Schwarz, DF Ware, JH Wedeen, RP Serwint, J Brophy, M Davoli, CT Denckla, MB Farfel, MR Goldstein, GW Rubin, J Berger, O Dietrich, KN Wesolowski, C Wilkins, S Maynard-Wentzel, G Mortensen, ME Adubato, S El-safty, M Heenehan, M Sheffet, A Ty, A Campbell, C Gill, FM Guinn, J Henretig, F Knight, D Radcliffe, J Schwarz, DF Bowman, BB Gunter, E Huff, D Jones, RL Miller, DT Paschal, DC Bernstein, AJ Kotlov, TV Salganik, M Angle, CR Faison, J Gehlbach, SH Gray-Little, B James, SA Moye, LA Needleman, HL

Citation: Rl. Bornschein et al., Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 mu g/dL, PEDIAT RES, 48(5), 2000, pp. 593-599

Authors: Henretig, F

Citation: F. Henretig, A national survey of Regional Poison Control Centers' management of occupational exposure calls (vol 41, pg 93, 1999), J OCCUP ENV, 41(5), 1999, pp. 404-404

Authors: Rogan, WJ Ragan, NB Damokosh, AI Davoli, C Shaffer, TR Jones, RL Wilkens, S Heenehan, MC Ware, JH Henretig, F

Citation: Wj. Rogan et al., Recall of a lead-contaminated vitamin and mineral supplement in a clinicaltrial, PHARMA D S, 8(5), 1999, pp. 343-350

Authors: Henretig, F

Citation: F. Henretig, Risperidone toxicity acknowledged, J TOX-CLIN, 37(7), 1999, pp. 895-895